Moderna #Merck #CancerResearch #MedicalTechnology

Moderna and Merck Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%

Moderna and Merck have announced detailed results from a major clinical trial showing that their experimental personalised cancer vaccine, intismeran…